Investigating a long noncoding RNA's role in aggressive brain tumors in children
Regulation, function, and the therapeutic potential of an oncogenic long noncoding RNA lnc-HLX-2-7 in group 3 medulloblastomas
This study is looking at a special RNA that might play a role in how a tough type of brain tumor, called group 3 medulloblastoma, grows in young kids, and the researchers hope to find new ways to help treat these tumors by testing how removing this RNA affects the tumor cells.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-10878986 on NIH RePORTER |
What this research studies
This research focuses on understanding the function of a specific long noncoding RNA, lnc-HLX-2-7, in group 3 medulloblastomas, a type of brain tumor that primarily affects young children. By utilizing machine learning and CRISPR technology, the study aims to explore how this RNA influences tumor growth and behavior. The researchers will analyze RNA sequencing data and conduct experiments to see how depleting lnc-HLX-2-7 affects tumor cells in laboratory settings and animal models. The ultimate goal is to identify new therapeutic strategies that could improve outcomes for children with these challenging tumors.
Who could benefit from this research
Good fit: Ideal candidates for this research are children under 11 years old diagnosed with group 3 medulloblastomas.
Not a fit: Patients with other types of brain tumors or those over the age of 11 may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to new targeted therapies that significantly improve survival rates and quality of life for children with aggressive medulloblastomas.
How similar studies have performed: Other research has shown promising results using similar approaches to target noncoding RNAs in cancer treatment, indicating potential for success in this area.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Perera, Ranjan Joseph — Johns Hopkins University
- Study coordinator: Perera, Ranjan Joseph
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.